Equillium, Inc. (EQ)
NASDAQ: EQ · Real-Time Price · USD
2.205
-0.065 (-2.86%)
Sep 1, 2026, 4:00 PM EDT - Market closed
Equillium Market Cap
Equillium has a market cap or net worth of $139.81 million as of September 1, 2026. Its market cap has increased by 35.04% in one year.
Market Cap
139.81M
Enterprise Value
83.23M
1-Year Change
35.04%
Ranking
Category
Stock Price
$2.21
ChartMarket Cap Chart
Since October 12, 2018, Equillium's market cap has decreased from $234.54M to $139.81M, a decrease of -40.39%. That is a compound annual growth rate of -6.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 139.81M | 48.13% |
| Dec 31, 2025 | 94.38M | 256.04% |
| Dec 31, 2024 | 26.51M | 4.40% |
| Dec 29, 2023 | 25.39M | -30.27% |
| Dec 30, 2022 | 36.41M | -67.14% |
| Dec 31, 2021 | 110.80M | -16.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kazia Therapeutics | 157.35M |
| Tenaya Therapeutics | 154.23M |
| Outlook Therapeutics | 154.20M |
| Indaptus Therapeutics | 152.56M |
| NRx Pharmaceuticals | 150.55M |
| OnKure Therapeutics | 147.00M |
| Unicycive Therapeutics | 144.85M |
| Connect Biopharma Holdings | 138.54M |